1. Home
  2. AYI vs CYTK Comparison

AYI vs CYTK Comparison

Compare AYI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acuity Brands Inc.

AYI

Acuity Brands Inc.

HOLD

Current Price

$339.61

Market Cap

10.3B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$78.38

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AYI
CYTK
Founded
2001
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
10.7B
IPO Year
2001
2004

Fundamental Metrics

Financial Performance
Metric
AYI
CYTK
Price
$339.61
$78.38
Analyst Decision
Buy
Strong Buy
Analyst Count
6
19
Target Price
$369.17
$89.26
AVG Volume (30 Days)
252.5K
1.8M
Earning Date
04-02-2026
05-05-2026
Dividend Yield
0.28%
N/A
EPS Growth
N/A
N/A
EPS
11.45
N/A
Revenue
$3,461,000,000.00
$13,368,000.00
Revenue This Year
$7.51
$7.37
Revenue Next Year
$5.14
$310.19
P/E Ratio
$29.40
N/A
Revenue Growth
4.05
N/A
52 Week Low
$257.04
$35.22
52 Week High
$380.17
$88.31

Technical Indicators

Market Signals
Indicator
AYI
CYTK
Relative Strength Index (RSI) 48.79 51.75
Support Level $335.50 $78.27
Resistance Level $375.91 $79.66
Average True Range (ATR) 7.89 2.47
MACD -2.57 0.22
Stochastic Oscillator 20.08 60.42

Price Performance

Historical Comparison
AYI
CYTK

About AYI Acuity Brands Inc.

Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. It designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: